Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A trial looking at a different way of giving posaconazole to prevent fungal infection after treatment for some blood cancers
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
More about this trial
Doctors can treat AML, MDS and CML with chemotherapy or a bone marrow or stem cell transplant. One of the side effects of both these treatments is a drop in white blood cells causing an increased risk of infection, including fungal infection.
Posaconazole is a drug that doctors use to treat or prevent fungal infection. It is a liquid that you swallow. The researchers developed another form of posaconazole that you have as a
The aims of this trial were to find out the
- Levels of posaconazole in the blood before and after having it through a drip
- Side effects of having posaconazole through a drip
- Levels of posaconazole in the blood after switching from having it as a drip to a liquid that is swallowed
Summary of results
Despite attempting to contact the trial team, we have not been able to have the results for this trial checked.
How to join a clinical trial
Dr Samir Agrawal
Merck, Sharp & Dohme
Schering Plough Research Institute